Triacylglycerol lipase
CAS 9001-62-1
Triacylglycerol lipase (CAS 9001-62-1) is a pharmaceutical compound with 0 bioactivity targets and 8 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Triacylglycerol lipase is linked to DTXSID0047458 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Triacylglycerol lipase used for in pharmaceutical contexts?
Triacylglycerol lipase (CAS 9001-62-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Triacylglycerol lipase?
Triacylglycerol lipase has 8 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal pain upper, Asthenia, Chest discomfort, Dizziness, Nausea. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Triacylglycerol lipase also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Lipase with EU status "permitted".
What clinical phase is Triacylglycerol lipase in?
No phase 1-4 clinical development badge is rendered for Triacylglycerol lipase because the matched compound identifier rows do not contain a max-phase value.